| Abstract | There have been three important double-blind studies evaluating the use of gold therapy in rheumatoid arthritis. Patients treated with gold have decreased number of joints with synovitis, decreased ring size, increased grip strength, and roentgenographic evidence of arrest or decrease in the progression of skeletal lesions. If a patient with active synovitis does not respond to nonsteroidal anti-inflammatory drugs after four months of treatment, he is a candidate for gold therapy. Maintenance gold therapy has been shown to sustain clinical improvement. Patients must be monitored with appropiate laboratory tests. |
| Authors | M Abeles, J D Urman, A Weinstein |
| Journal | Southern medical journal
(South Med J)
Vol. 70
Issue 5
Pg. 604-6
(May 1977)
ISSN: 0038-4348 UNITED STATES |
| PMID | 404715
(Publication Type: Clinical Trial, Journal Article)
|
| Chemical References |
|
| Topics |
- Arthritis, Rheumatoid
(therapy)
- Clinical Trials as Topic
- Gold Sodium Thiomalate
(adverse effects, metabolism, pharmacology, therapeutic use)
- Hematologic Diseases
(chemically induced)
- Humans
- Nephritis
(chemically induced)
- Skin Diseases
(chemically induced)
- Synovitis
(therapy)
|
